NCT06416761 Genetics in the Progression of Nephropathies
| NCT ID | NCT06416761 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ospedale San Raffaele |
| Condition | AKI |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2006-05-19 |
| Primary Completion | 2040-05-19 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2006-05-19 with a primary completion date of 2040-05-19.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates the role of genetic in the development and progression of different nephropaties with particular attention to: * AKI * CKD * Hypertension * ADPKD * CKD-MBD * Patients with decompensated heart failure undergoing either medical or surgery therapy * Patients with hematologic cancer exposed to chemotherapeutic agents or undergoing allogeneic bone marrow transplantation * glomerular diseases
Eligibility Criteria
Inclusion Criteria: . presence of specific renal disease Exclusion Criteria: * to be evaluated in the different sub-protocols
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06416761 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying AKI. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06416761 currently recruiting?
Yes, NCT06416761 is actively recruiting participants. Contact the research team at lanzani.chiara@hsr.it for enrollment information.
Where is the NCT06416761 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT06416761 clinical trial?
NCT06416761 is sponsored by Ospedale San Raffaele. The trial plans to enroll 10,000 participants.